Gene · 2395
Papers2,919
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 2,919
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Diagnostic yield and limitations of whole-genome sequencing for hereditary cerebellar ataxia. | Brain Commun | 2025 | 40488180 | PubTator, text mining | PubMed |
| Anti-gene oligonucleotides targeting Friedreich's ataxia expanded GAA⋅TTC repeats increase Frataxin expression. | Mol Ther Nucleic Acids | 2025 | 40487352 | PubTator, text mining | PubMed |
| Base editing of trinucleotide repeats that cause Huntington's disease and Friedreich's ataxia reduces somatic repeat expansions in patient cells and in mice. | Nat Genet | 2025 | 40419681 | PubTator, text mining | PubMed |
| Inhibition of Rho-Associated Kinases ROCK1 and ROCK2 as a Therapeutic Strategy to Reactivate the Repressed FXN Gene in Friedreich Ataxia. | J Neurosci | 2025 | 40404357 | PubTator, text mining | PubMed |
| Frataxin: from the sequence to the biological role. | Biophys Rev | 2025 | 40376404 | PubTator, text mining | PubMed |
| Therapeutic combination of L-ascorbic acid, N-acetylcysteine, and dimethyl fumarate in Friedreich's ataxia: insights from in vitro models. | Redox Rep | 2025 | 40375363 | PubTator, text mining | PubMed |
| Metformin aggravates pancreatitis by regulating the release of oxidised mitochondrial DNA via the frataxin (FXN)/ninjurin 1 (NINJ1) signalling pathway. | Br J Pharmacol | 2025 | 40344214 | PubTator, text mining | PubMed |
| Redox homeostasis and inflammation in fibroblasts of patients with Friedreich Ataxia: a possible cross talk. | Front Mol Neurosci | 2025 | 40308559 | PubTator, text mining | PubMed |
| Brain microvascular endothelial cells differentiated from a Friedreich's Ataxia patient iPSC are deficient in tight junction protein expression and paracellularly permeable. | Front Mol Neurosci | 2025 | 40303283 | PubTator, text mining | PubMed |
| Model-guided design of microRNA-based gene circuits supports precise dosage of transgenic cargoes into diverse primary cells. | Cell Syst | 2025 | 40300600 | PubTator, text mining | PubMed |
| MSH2 is not required for either maintenance of DNA methylation or repeat contraction at the FMR1 locus in fragile X syndrome or the FXN locus in Friedreich's ataxia. | Epigenetics Chromatin | 2025 | 40296143 | PubTator, text mining | PubMed |
| ONT in Clinical Diagnostics of Repeat Expansion Disorders: Detection and Reporting Challenges. | Int J Mol Sci | 2025 | 40141365 | PubTator, text mining | PubMed |
| Nomlabofusp, a Fusion Protein of Human Frataxin and a Cell Penetrant Peptide, Delivers Mature and Functional Frataxin into Mitochondria. | AAPS J | 2025 | 40140196 | PubTator, text mining | PubMed |
| Robust behavioral assessment of the inducible Friedreich's ataxia mouse does not show improvement with NRF2 induction. | Dis Model Mech | 2025 | 40017373 | PubTator, text mining | PubMed |
| Frataxin deficiency and the pathology of Friedreich's Ataxia across tissues. | Tissue Barriers | 2025 | 39981684 | PubTator, text mining | PubMed |
| Frataxin Traps Low Abundance Quaternary Structure to Stimulate Human Fe-S Cluster Biosynthesis. | Biochemistry | 2025 | 39909887 | PubTator, text mining | PubMed |
| Recent advances in self-targeting natural product-based nanomedicines. | J Nanobiotechnology | 2025 | 39833846 | PubTator, text mining | PubMed |
| Friedreich Ataxia: An (Almost) 30-Year History After Gene Discovery. | Neurol Genet | 2025 | 39810753 | PubTator, text mining | PubMed |
| Friedreich ataxia: what can we learn from non-GAA repeat mutations? | Neurodegener Dis Manag | 2025 | 39810561 | PubTator, text mining | PubMed |
| Altered Ca2+ responses and antioxidant properties in Friedreich's ataxia-like cerebellar astrocytes. | J Cell Sci | 2025 | 39648860 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2395/papers?page=6